Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2167 Target Snapshot

GTPase HRas · SINGLE PROTEIN · Homo sapiens

111Compounds
36Assays
1Approved Drugs
76.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P01112. Use UniProt P01112 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P01112 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats GTPase HRas as ChEMBL target CHEMBL2167, mapped to UniProt P01112. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
GTPase HRas
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2167
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P01112
GTPase HRas
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether GTPase HRas is the right protein anchor across sources, using UniProt P01112 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGTPase HRas
UniProt AccessionP01112
Component TypeProtein
Sequence Length189 aa

GTPase HRas

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as GTPase HRas, mapped to UniProt P01112. Sequence length is 189 aa.

Mapped IDP01112
Review nameGTPase HRas
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase II
2
Phase I
Assay Mix

Activity Type Distribution

IC5064.0
KI1.0
EC503.0
KD8.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL351706 8.89 IC50 1.3 Preclinical
CHEMBL279433 8.8 Ki 1.6 Preclinical
CHEMBL66699 8.72 IC50 1.9 Preclinical
CHEMBL554189 7.82 IC50 15.0 Preclinical
CHEMBL554247 7.82 IC50 15.0 Preclinical
CHEMBL552690 7.82 IC50 15.0 Preclinical
CHEMBL554353 7.82 IC50 15.0 Preclinical
CHEMBL540313 7.82 IC50 15.0 Preclinical
CHEMBL552863 7.7 IC50 20.0 Preclinical
CHEMBL536328 7.7 IC50 20.0 Preclinical
Distribution

pChEMBL Value Distribution

15
5.0
3
5.5
5
6.0
6
6.5
4
7.0
7
7.5
0
8.0
4
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

LONAFARNIB
CHEMBL298734
Approved 2020
Assay Landscape

Assay Landscape

36
Total Assays
49
Tested Compounds
2
Assay Types
Binding — 33 assays, 49 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 15 40 5.8
assay format 12 7 5.2
cell-based format 6 2 5.4
Functional — 3 assays, 15 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 15 6.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine